Chelmsford, Massachusetts, United States ZOLL Medical Corporation appeared to be the Corporate Investor, which was created in 1980. The leading representative office of defined Corporate Investor is situated in the Chelmsford. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the ZOLL Medical Corporation, startups are often financed by Sorin Group, Kleiner Perkins. The meaningful sponsors for the fund in investment in the same round are Wellington Management, Versant Ventures, Sorin Group.
We can highlight the next thriving fund investment areas, such as Health Care, Medical. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight TherOx, Respicardia. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2008.
Related Funds
| Fund Name | Location |
| Clal Electronics Industries | - |
| Feiteng Chuangtou | China, Guangdong, Shenzhen |
| First Albany Companies | Albany, New York, United States |
| GKM | California, Los Angeles, United States |
| Mistral Equity Partners | New York, New York, United States |
| Northwest Venture Associates | Spokane, United States, Washington |
| QVT Financial | New York, New York, United States |
| The MasterCard Foundation | Canada, Ontario, Toronto |
| Zuo'An Capital | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 